JN

Joi Ninomoto

Executive Scientific Director, Clinical Development at Summit Therapeutics, Inc.

Joi Ninomoto is an experienced professional in the field of oncology clinical development and business development strategies. With a background in pharmacy and genetics, Joi has held various impactful roles in companies such as Summit Therapeutics, Pharmacyclics, Geron, and SuperGen, Inc. Currently serving as the Executive Scientific Director in Clinical Development, Joi's extensive experience and education make them a valuable asset in the pharmaceutical industry.

Links

Previous companies

Amgen logo
Geron logo
Dana-Farber Cancer Institute logo

Timeline

  • Executive Scientific Director, Clinical Development

    October, 2021 - present

A panel showing how The Org can help with contacting the right person.